Studies On Mold Extracts As Potential Therapeutic Agents For Hepatitis C And Dengue Diseases

Dengue (DENV) and hepatitis C viruses (HCV) are from the Flaviviridae family. DENV causes 50 -100 million dengue hemorrhagic fever or dengue shock syndrome with more than 20, 000 deaths globally. While HCV causes chronic liver diseases to 150 million people globally. Up to date there is no antiviral...

Full description

Saved in:

Bibliographic Details
Main Author:	Sandanamsamy, Sylvia Sandanasamy
Format:	Thesis
Language:	English
Published:	2020
Subjects:	T11.95-12.5 Industrial directories
Online Access:	http://eprints.usm.my/55654/1/SYLVIA%20THESIS%20cut.pdf
Tags:	Add Tag No Tags, Be the first to tag this record!

id	my-usm-ep.55654
record_format	uketd_dc
spelling	my-usm-ep.556542022-11-15T06:51:51Z Studies On Mold Extracts As Potential Therapeutic Agents For Hepatitis C And Dengue Diseases 2020-01 Sandanamsamy, Sylvia Sandanasamy T11.95-12.5 Industrial directories Dengue (DENV) and hepatitis C viruses (HCV) are from the Flaviviridae family. DENV causes 50 -100 million dengue hemorrhagic fever or dengue shock syndrome with more than 20, 000 deaths globally. While HCV causes chronic liver diseases to 150 million people globally. Up to date there is no antiviral drug for DENV while HCV antivirals are performing below par. In the search for an antiviral drug for HCV and DENV, extracts from Malaysian fungal isolates were tested. Fifty five fungal isolates were fermented separately on three different media namely, potato dextrose broth (PDB), complex media without phenylacetic acid (CM) and complex media with phenylacetic acid (CM+PA) at 30°C for 5 days. Mycelia-free supernatants were extracted (1:1) using methanol and ethyl acetate which produced 165 methanolic and 165 ethyl acetate crude extracts. Crude extracts (73 ethyl acetate and 61 methanolic) were subjected to HCV NS3/NS4A protease assay and extract with more than 95% inhibition activity were further fractionated using column chromatography. Determination of inhibition concentration at 50% (IC50), cytotoxicity and Gas Chromatography Mass Spectrometry (GCMS) analysis were performed on best active subfraction. Fungal isolate were identified using 18S rDNA sequencing. Crude extracts (45 ethyl acetate and 37 methanolic) that gave more than 80% HCV protease inhibition coherently were tested for DENV NS2B/NS3 protease inhibition activity. Most active crude extract was further fractionated and subfractions were tested using DENV NS2B/NS3 protease inhibition activity. 2020-01 Thesis http://eprints.usm.my/55654/ http://eprints.usm.my/55654/1/SYLVIA%20THESIS%20cut.pdf application/pdf en public phd doctoral Universiti Sains Malaysia Pusat Pengajian Teknologi Industri
institution	Universiti Sains Malaysia
collection	USM Institutional Repository
language	English
topic	T11.95-12.5 Industrial directories
spellingShingle	T11.95-12.5 Industrial directories Sandanamsamy, Sylvia Sandanasamy Studies On Mold Extracts As Potential Therapeutic Agents For Hepatitis C And Dengue Diseases
description	Dengue (DENV) and hepatitis C viruses (HCV) are from the Flaviviridae family. DENV causes 50 -100 million dengue hemorrhagic fever or dengue shock syndrome with more than 20, 000 deaths globally. While HCV causes chronic liver diseases to 150 million people globally. Up to date there is no antiviral drug for DENV while HCV antivirals are performing below par. In the search for an antiviral drug for HCV and DENV, extracts from Malaysian fungal isolates were tested. Fifty five fungal isolates were fermented separately on three different media namely, potato dextrose broth (PDB), complex media without phenylacetic acid (CM) and complex media with phenylacetic acid (CM+PA) at 30°C for 5 days. Mycelia-free supernatants were extracted (1:1) using methanol and ethyl acetate which produced 165 methanolic and 165 ethyl acetate crude extracts. Crude extracts (73 ethyl acetate and 61 methanolic) were subjected to HCV NS3/NS4A protease assay and extract with more than 95% inhibition activity were further fractionated using column chromatography. Determination of inhibition concentration at 50% (IC50), cytotoxicity and Gas Chromatography Mass Spectrometry (GCMS) analysis were performed on best active subfraction. Fungal isolate were identified using 18S rDNA sequencing. Crude extracts (45 ethyl acetate and 37 methanolic) that gave more than 80% HCV protease inhibition coherently were tested for DENV NS2B/NS3 protease inhibition activity. Most active crude extract was further fractionated and subfractions were tested using DENV NS2B/NS3 protease inhibition activity.
format	Thesis
qualification_name	Doctor of Philosophy (PhD.)
qualification_level	Doctorate
author	Sandanamsamy, Sylvia Sandanasamy
author_facet	Sandanamsamy, Sylvia Sandanasamy
author_sort	Sandanamsamy, Sylvia Sandanasamy
title	Studies On Mold Extracts As Potential Therapeutic Agents For Hepatitis C And Dengue Diseases
title_short	Studies On Mold Extracts As Potential Therapeutic Agents For Hepatitis C And Dengue Diseases
title_full	Studies On Mold Extracts As Potential Therapeutic Agents For Hepatitis C And Dengue Diseases
title_fullStr	Studies On Mold Extracts As Potential Therapeutic Agents For Hepatitis C And Dengue Diseases
title_full_unstemmed	Studies On Mold Extracts As Potential Therapeutic Agents For Hepatitis C And Dengue Diseases
title_sort	studies on mold extracts as potential therapeutic agents for hepatitis c and dengue diseases
granting_institution	Universiti Sains Malaysia
granting_department	Pusat Pengajian Teknologi Industri
publishDate	2020
url	http://eprints.usm.my/55654/1/SYLVIA%20THESIS%20cut.pdf
_version_	1776101104145137664

Studies On Mold Extracts As Potential Therapeutic Agents For Hepatitis C And Dengue Diseases

Similar Items